CLEAN-TAVI Trial Shows Claret Medical Cerebral Protection System Dramatically Reduces Brain Lesions and Neurological Events Following Transcatheter Aortic Valve Replacement (TAVR)
Clinical Trial is First to Definitively Demonstrate That Removing Embolic Debris from Cerebral Circulation Can Significantly Shield the Brain TCT